Praxis Precision Medicines (PRAX) stock gain as the company speed up R&D plans for its seizure drug relutrigine following ...

For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

U.S. Immigration and Customs Enforcement (ICE) has responded after a video shared widely on social media showed agents taking ...

In today’s Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart ...

EMA’s PRIME designation bolsters Neurona’s global development strategy and underscores the company’s commitment to bringing NRTX-1001 interneuron cell therapy to patients worldwide.

And they feel lucky. The waitlist for treatment is three months long and ever-growing, according to Shriti Patel, who ...

Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulatorDeepens Axsome’s broad ...

The Brain and Spine Program at Intermountain Primary Children’s Hospital has been ranked 16th in the nation among all ...

This week, Bobbi Conner talks with MUSC's Dr. Sarah Schmitt about epilepsy and common triggers that may initiate a seizure in ...

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...

"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults," the authors wrote. "The bidirectional associations we observed suggest ...